http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2648877-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdf96aebafc10d47b8e96dd033377fdd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-03
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-03
filingDate 2017-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bada5df9d6b94a87cfc7053e25a8e005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e74c2f794faa1c32dfd340c6ae0b9f48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae065c962e77aac3bc91082a7324c035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b6f0c5ee5cdcdb851cfa16e690ca4ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89eb386d84f425a3aebb95d7f8bb1514
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1283bd5347a859d0ccf6110d4f21e41f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fd148d06a0406558ab5a8f8abc12cb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f921ea54484f3fdb7ccea1e45401f37d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c23b47c75cb2177ec31315d0345647a
publicationDate 2018-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2648877-C1
titleOfInvention Method for inflammation foci identification by the method of poly-organic scintigraphy
abstract FIELD: medicine. n SUBSTANCE: invention relates to the field of medicine, namely, to radionuclide diagnostics and can be used to identify inflammation foci using the multi-organ scintigraphy technique. Performing the blood sampling of at least 250–400 ml into the first sterile bag, which is centrifuged at a speed of 800 rpm for the time required to precipitate the red blood cells. Enriched with leukocytes supernatant plasma is transferred into the second bag. Contents of the second bag is centrifuged at a speed of 1,300 rpm for the time required to obtain auto-leukocytes. Then, the supernatant plasma from the second bag is transferred to the third bag, and the red cells from the first bag are intravenously returned to the patient. Adding the radiopharmaceutical preparation (RFP) in an amount of 3–5 ml into the remaining in the second bag auto-leukocytes. Resulting cells suspension is incubated for 8–10 minutes. To this, plasma from the third bag is added in an amount of 10–20 ml, followed by centrifugation of the second bag with the resulting cells suspension at a speed of 2,000 rpm for the time necessary to separate the labeled auto-leukocytes from free RFP that has not been bound to leukocytes. Removing the free RFP from the second bag. Adding the remaining plasma into labeled auto-leukocytes and from the third bag and resuspending to obtain a preparation that is administered to the patient for multi-organ scintigraphy. n EFFECT: method provides an increase in the reliability of the inflammation foci determination, that is, obtaining more objective results of the study, due to using a blood cells preparation characterized by the absence of free radioactivity and impurities of labeled auto-erythrocytes, while maintaining functional properties of the cellular elements, as well as a qualitative evaluation of the labeled leukocytes accumulation in the proposed zone of inflammation by visual and quantitative determination of the RFP increased accumulation area. n 1 cl, 10 dwg, 8 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2708458-C2
priorityDate 2017-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2261656-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2290952-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449676699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23957

Total number of triples: 33.